ADVANCED SYSTEMIC MASTOCYTOSIS

ADVANCED SYSTEMIC MASTOCYTOSIS was reported 18 times

ADVANCED SYSTEMIC MASTOCYTOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Alkylating Drug [EPC] 4 0.0000
1 CD20-directed Cytolytic Antibody [EPC] 5 0.0000
2 Anti-IgE [EPC] 1 0.0000
3 Interleukin-23 Antagonist [EPC] 1 0.0000
4 Kinase Inhibitor [EPC] 5 0.0000
5 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
6 Corticosteroid [EPC] 4 0.0000